MNCHIP

What MNCHIP does

MNCHIP (legal entity: Tianjin MNCHIP Technologies Co., Ltd) is a Chinese in-vitro diagnostics manufacturer founded in 2010 in Tianjin under the auspices of Legend Holdings. The company designs and sells automated clinical chemistry analyzers based on proprietary microfluidics technology, in which reagent discs with colorimetric holes replace the conventional cuvettes of traditional blood analyzers. This architecture enables multi-parameter blood chemistry testing from a 100 µl blood sample (12 µl reaction volume, approximately 2 µl of blood) with results delivered in 7-12 minutes per run, addressing point-of-care use cases where low blood volume, speed, and decentralization are critical — notably NICU and Paediatric testing, fever clinics, and small-animal veterinary diagnostics.

The product portfolio spans the Celercare and Pointcare lines (Celercare M5, Pointcare M4 for medical; Celercare V5, Pointcare V3, Pointcare PCR V1 for veterinary), plus the Helo 300 clinical instrument line. Reagent discs are sold as recurring consumables across multiple panels (General Chemistry, Liver Function, Renal Function, Electrolyte, Glucose and Lipid, Ammonia, Clinical Emergency, HCY), creating a razor-and-blade revenue model layered on top of instrument sales. Manufacturing is split between Tianjin (R&D and commercial headquarters) and a Suzhou branch opened in 2017 for production scale-up. Distribution combines direct enterprise sales in China with an international distributor network covering 80+ countries; trade show presence spans Medlab Asia, Medlab Middle East, Africa Health, Medica, and CACLP. Regulatory footprint includes ISO 13485:2016, CE Declaration of Conformity, and NMPA medical device manufacturer licensing.

Revenue is generated through one-time hardware sales of chemistry analyzers and ongoing sales of consumable reagent discs, with quote-based pricing and multi-year contract cadence. The customer base is fragmented across human medical institutions ("thousands of medical institutions" across China) and veterinary clinics/animal hospitals, with 20,000+ devices deployed globally by 2022. The company is privately held with no public listing; disclosed funding totals roughly $5.3M across three rounds between 2011 and 2015, with Legend Capital as the most recent lead investor.

Name

MNCHIP

Legal name

Tianjin MNCHIP Technologies Co.,Ltd

Website

https://en.mnchip.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

251–500 employees

Short description

MNCHIP is a Chinese in-vitro diagnostics company founded in 2010 that designs microfluidic clinical chemistry analyzers and reagent disc consumables for point-of-care blood testing in human hospitals and veterinary clinics, with 20,000+ devices deployed across 80+ countries.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics — Point-of-Care Clinical Chemistry Analyzers

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industry

Laboratory Consumables & Plasticware (Tips, Tubes, Plates, Filters) (HLAGAIAH)

Keywords

• In vitro diagnostics
• Point-of-care chemistry analyzer
• Microfluidic blood testing
• Veterinary clinical chemistry
• Reagent disc consumables

Headquarters

HQ city

Wuqing

HQ country

China

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Chemistry Analyzer Hardware Sales: Sale of automated clinical chemistry analyzers including Pointcare and Celercare product lines for medical and veterinary diagnostics.
2. Reagent Disc Consumables: Reagent discs with various test panels (General Chemistry, Liver Function, Renal Function, Electrolyte, Glucose and Lipid, Ammonia, Clinical Emergency, etc.) that are consumed with each test run.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

MNCHIP designs, manufactures, and sells microfluidics-based automated clinical chemistry analyzers (Celercare and Pointcare product lines) along with proprietary single-use reagent discs for point-of-care blood chemistry testing. Its systems serve hospitals, clinics, ICUs, fever clinics, and veterinary practices, delivering multi-parameter diagnostic results from approximately 100μl of whole blood within 7-12 minutes. The reagent disc consumables (general chemistry, liver/renal function, electrolytes, glucose/lipid, ammonia, HCY panels) generate ongoing recurring revenue tied to instrument installed base.

Differentiator

Problem solved

Functional benefit

Brands

• Celercare: Point-of-care chemistry analyzer product line for medical diagnostics.
• Pointcare
• Helo

Products and services

• Celercare M5 Fully automated, higher-throughput point-of-care clinical chemistry analyzer for medical settings, using microfluidic reagent discs and a touchscreen console to deliver multi-parameter blood chemistry results within 7-12 minutes.
• Pointcare M4 Compact point-of-care clinical chemistry analyzer for medical settings, delivering the same microfluidic performance as Celercare M5 in a smaller form factor with different throughput, screen, and size to suit clinics and smaller wards.
• Pointcare M3 Compact fully automatic biochemistry analyzer positioned by MNCHIP as the world's smallest chemistry analyzer, designed for point-of-care medical blood chemistry testing.
• Celercare V5 Veterinary point-of-care chemistry analyzer for animal hospitals and veterinary clinics, providing rapid multi-parameter blood chemistry for pets and animals from small sample volumes.
• Pointcare V Series Veterinary chemistry analyzer product line within the Pointcare family, including Pointcare V3 and Pointcare PCR V1, used by veterinary clinics for in-clinic blood chemistry profiling.
• Helo 300 Series Clinical Instruments Clinical instrument line under the Helo brand, expanding MNCHIP's diagnostic capability beyond core chemistry analyzers into additional medical and veterinary testing applications.
• Microfluidic Reagent Discs Proprietary single-use reagent discs that run on MNCHIP chemistry analyzers, integrating multiple parameter indexes on one disc with a 12μl reaction volume using only about 2μl of blood per test, including General Chemistry, Liver Function, Renal Function, Electrolyte, Glucose and Lipid, Ammonia, and Clinical Emergency panels.
• GLU & Lipid & HCY Panel Lyophilized Kit Lyophilized reagent kit for the MNCHIP automated chemistry analyzer, bundling HCY, TG, CHOL, HDL-C, LDL-C, and GLU assays to support screening and monitoring of cardiovascular disease, diabetes complications, chronic renal failure, and pulmonary thromboembolism.

Quantifiable outcome

• Blood volume reduction of 75% compared to traditional blood chemistry testing
• +3 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Heska (Antech Diagnostics): Heska, acquired by Antech/Mars Petcare, offers point-of-care veterinary chemistry analyzers and laboratory services. It competes head-to-head with MNCHIP's veterinary chemistry line in companion animal practices.
• Abaxis (Zoetis): Abaxis, now part of Zoetis, pioneered compact blood chemistry analyzers for both human point-of-care and veterinary use. It is one of the closest direct competitors to MNCHIP, particularly in the veterinary diagnostics segment where Abaxis historically dominated with the VetScan product line.
• Nova Biomedical: Nova Biomedical is a privately held US manufacturer of critical care and point-of-care blood chemistry analyzers (e.g., Stat Profile series). Its StatStrip and Nova series directly compete with MNCHIP's microfluidic-based POCT chemistry analyzers in hospital and clinic settings.
• IDEXX Laboratories: IDEXX is the global leader in veterinary diagnostics, offering the Catalyst One and Catalyst Dx chemistry analyzers widely used in companion animal clinics. It directly competes with MNCHIP's Pointcare V and Celercare V veterinary product lines.
• Randox Laboratories: Randox is a privately held UK clinical chemistry and immunoassay manufacturer offering the Evidence and RX series analyzers. It competes with MNCHIP in compact benchtop clinical chemistry analyzers, particularly in international markets and resource-limited settings.
• ELITechGroup: ELITechGroup manufactures clinical chemistry analyzers and reagents, including the Selectra series, sold globally with strong presence in Europe and emerging markets. It is comparable to MNCHIP as a mid-sized clinical chemistry manufacturer competing for the same hospital/clinic chemistry segment.

Broad incumbents

• Abbott (i-STAT): Abbott's i-STAT system is a dominant handheld POC clinical chemistry/blood gas analyzer used in hospitals worldwide. As a broad IVD incumbent, Abbott competes with MNCHIP in the hospital point-of-care chemistry segment but offers a much wider diagnostic portfolio.
• Roche Diagnostics: Roche Diagnostics is the global IVD market leader with the cobas platform spanning clinical chemistry, immunoassay, and molecular diagnostics. Its large installed base in hospitals represents the primary competitive backdrop against which MNCHIP's POCT chemistry offering must differentiate.
• Siemens Healthineers: Siemens Healthineers offers the Atellica and Dimension clinical chemistry analyzers, plus a broad IVD portfolio. Its scale, service network, and integrated lab solutions represent the dominant competitive incumbent in central lab chemistry to which MNCHIP's POCT offering is positioned as an alternative.

Regional players

• Mindray (Shenzhen Mindray Bio-Medical Electronics): Mindray is a leading Chinese IVD and medical device manufacturer with a broad clinical chemistry and hematology portfolio. As a fellow China-headquartered IVD company, Mindray is comparable in business model and international expansion trajectory, though it operates at substantially greater scale than MNCHIP.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks2 records

Key highlights7 records

Customer concentration

• Xx.com/mnchipinternat1

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds3 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MNCHIP